Dr. Wouter Leemans Neurologie SRL
Dr. Wouter Leemans Neurologie reported total assets of 136,486 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Apr 2026).
The score of Dr. Wouter Leemans Neurologie shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Wouter Leemans Neurologie's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 30 Apr 2026
- Year ended 30 Sep 2024filed on 28 Apr 2025
Dr. Wouter Leemans Neurologie's financial analysis
- Solvency85.5%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Wouter Leemans Neurologie
Dr. Wouter Leemans Neurologie's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0804.896.595
- VAT number
- BE0804896595
- Peppol
- Registered · 0208:0804896595 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Aug 2023
- Registered office
- 2300 Turnhout
- Latest accounts
- 2025 · filed on 30 Apr 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Wouter Leemans Neurologie (SRL) has been based in Turnhout since 2023, active in: medical specialists activities. For 2025, it reports a net profit of 70,559 € and equity of 116,630 €; its revenue is not published. Its solvency stands at 85.5%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Wouter Leemans Neurologie
Companies in the same business, of comparable size and area, outside its group.
- Dr. Christophe Lebrun Medical specialists activities Oud-Turnhout · balance sheet 135,974 €
- Pierre - Andre de Berdt Medical specialists activities Waterloo · balance sheet 135,039 €
- Docteur Eurydice Noblesse Medical specialists activities Aubange · balance sheet 138,198 €
- Oogartsenpraktijk dokter Chris De Smet Medical specialists activities Lommel · balance sheet 138,268 €
- MDTX Anesthésie Medical specialists activities Rixensart · balance sheet 136,676 €
- Mairlot Derm Medical specialists activities Namur · balance sheet 136,835 €
- Barchiche Reda,Docteur Medical specialists activities Vilvoorde · balance sheet 136,921 €
- MARTY Médicale Medical specialists activities Ottignies-Louvain-la-Neuve · balance sheet 135,922 €
Frequently asked questions about Dr. Wouter Leemans Neurologie
What is the revenue of Dr. Wouter Leemans Neurologie?
Dr. Wouter Leemans Neurologie files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Wouter Leemans Neurologie?
In Belgium, the VAT number is the company number prefixed with BE: BE0804896595 for Dr. Wouter Leemans Neurologie, if the company is VAT-registered. Its company number (CBE) is 0804.896.595.
Where is the registered office of Dr. Wouter Leemans Neurologie?
According to the CBE register, the registered office of Dr. Wouter Leemans Neurologie is in 2300 Turnhout.
What is the equity of Dr. Wouter Leemans Neurologie?
At the close of the 2025 financial year, the equity of Dr. Wouter Leemans Neurologie amounts to 116,630 €, a solvency of 85.5% of total assets.
Who manages Dr. Wouter Leemans Neurologie?
The register lists 1 active mandates at Dr. Wouter Leemans Neurologie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Wouter Leemans Neurologie
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →